News |

Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.

ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.

This month's Legal Eagle column explores what information is required during an informed consent discussion.

Atopic dermatitis is not a "one-size-fits-all" condition.

It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.

This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.

Explore a collection of the best skin tips for patients with skin of color.

Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.

Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.

Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.

Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.

Preventing generalized pustular psoriasis may be possible based on recent data.

Click here to answer this week's poll.

This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, previews his laser session and live injectable demonstration at Maui Derm Hawaii 2023.

ICYMI, this week we had stories about conference coverage from Winter Clinical Hawaii, generalized pustular psoriasis management, nutritional supplements for hair loss, and more.

This week's edition of the Mainstream Patient features stories about inclusive beauty tools, how to build a better body-care routine, 5 hydrating face washes, and more.

Dermatologists have long warned tan seekers about the detrimental effects of ultraviolet exposure and tanning beds, strongly discouraging their use; nasal tanning sprays are no different.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews the founder of dermstore.com.

List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Amy Brodsky, MD, about her new skin care line.

As practices grow and become more intimately involved in patients’ complete health care — including regimens of sleep, nutrition, lifestyle, and even wearables — there is more room for lapses, errors or disagreements that pose questions suitable for lawyers.

Breakthroughs and approvals we can expect in the coming year.

Your practice’s finances are the key to long-term business success and understanding them doesn’t have to feel like a puzzle.

This week's edition of the Mainstream Patient features stories about PRP injections, sulfate-free shampoos for healthier hair, eczema creams for dry skin, and more.

Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.

ICYMI, this week we had stories about what to look forward to in 2023, psoriasis challenges, NDA submissions for berdazimer gel, and more.

Potential FDA approval is expected in the first quarter of 2024.